Advanced company searchLink opens in new window

G2B PHARMA LIMITED

Company number 10877587

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
31 Mar 2020 GAZ2(A) Final Gazette dissolved via voluntary strike-off
14 Jan 2020 GAZ1(A) First Gazette notice for voluntary strike-off
02 Jan 2020 DS01 Application to strike the company off the register
10 Dec 2019 TM01 Termination of appointment of Horacio Luis De Brito Carvalho as a director on 29 November 2019
11 Sep 2019 CS01 Confirmation statement made on 20 July 2019 with no updates
07 May 2019 AA Total exemption full accounts made up to 31 July 2018
20 Dec 2018 AD01 Registered office address changed from Unit 12 10 Acklam Road London W10 5QZ United Kingdom to Suite a, Second Floor, Barry House 20-22 Worple Road London SW19 4DH on 20 December 2018
02 Oct 2018 TM01 Termination of appointment of Michael Egerton Doodson as a director on 25 September 2018
05 Sep 2018 CS01 Confirmation statement made on 20 July 2018 with no updates
08 Aug 2017 AP01 Appointment of Mr Nigel Fleming as a director on 28 July 2017
03 Aug 2017 AP01 Appointment of Mr Horacio Luis De Brito Carvalho as a director on 21 July 2017
03 Aug 2017 AP01 Appointment of Mr Michael Egerton Doodson as a director on 21 July 2017
21 Jul 2017 TM01 Termination of appointment of Richard Turner as a director on 21 July 2017
21 Jul 2017 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2017-07-21
  • GBP 1